SPARC and neoplasm: when targeting the tumor site, HSMONs were endocytosed by tumor cells through another albumin receptor-secreted protein acidic and rich in cysteine (SPARC) and the high GSH level triggered the degradation of HSMONs, thereby releasing the payload only inside the tumor cells [29,30].